Design, Synthesis and Biological Activity of Novel Furocoumarin Derivatives as Stimulators of Melanogenesis and Tyrosinase in B16 Cells

Chao Niu , Deng Zang , Haji Akber Aisa

Chemical Research in Chinese Universities ›› 2018, Vol. 34 ›› Issue (3) : 408 -414.

PDF
Chemical Research in Chinese Universities ›› 2018, Vol. 34 ›› Issue (3) : 408 -414. DOI: 10.1007/s40242-018-7338-4
Article

Design, Synthesis and Biological Activity of Novel Furocoumarin Derivatives as Stimulators of Melanogenesis and Tyrosinase in B16 Cells

Author information +
History +
PDF

Abstract

Sixteen novel and four known(4a, 4d, 4e, 4h) amine derivatives of furocoumarin were synthesized, then submitted to evaluation as stimulators of melanogenesis and tyrosinase in B16 murine cells. Among them, five compounds(4g, 4j―4m) showed potent activating effect on both melanogenesis and tyrosinase in vitro compared with positive control(8-MOP), the most widely used drugs for vitiligo in clinic. Noticeably, compounds 4h and 4j, which contain morpholine and piperazine, were recognized as the most effective stimulator of melanogenesis and tyrosianse in B16 cells separately. These derivatives may serve as lead compounds for further drug discovery for the treatment of vitiligo.

Keywords

Furocoumarin / Amine / Melanin synthesis / Tyrosinase / Vitiligo

Cite this article

Download citation ▾
Chao Niu, Deng Zang, Haji Akber Aisa. Design, Synthesis and Biological Activity of Novel Furocoumarin Derivatives as Stimulators of Melanogenesis and Tyrosinase in B16 Cells. Chemical Research in Chinese Universities, 2018, 34(3): 408-414 DOI:10.1007/s40242-018-7338-4

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Ezzedine K., Sheth V., Rodrigues M., Eleftheriadou V., Harris J. E., Hamzavi I. H., Pandya A. G. J. Am. Acad. Dermatol., 2015, 73(5): 883.

[2]

Ezzedine K., Lim H. W., Suzuki T., Katayama I., Hamzavi I., Lan C. C., Goh B. K., Anbar T. Silva de Castro C., Lee A.Y., Parsad D., van Geel N., Poole I. C., Oiso N., Benzekri L., Spritz R., Gauthier Y., Hann S. K., Picardo M., Taieb A., Pigm. Cell Melanoma Res., 2012, 25(3): E1.

[3]

Harris J. E. J. Invest. Dermatol., 2015, 135(12): 2921.

[4]

Alikhan A., Felsten L., Daly M., Petronic-Rosic V. J. Am. Acad. Dermatol., 2011, 65(3): 473.

[5]

Laddha N. C., Dwivedi M., Mansuri M. S., Gani A. R., Ansarullah M., Ramachandran A.V., Dalai S., Begum R. Exp. Dermatol., 2013, 22(4): 245.

[6]

Spritz R. A. J. Invest. Dermatol., 2011, 131(3): e18.

[7]

Sandoval-Cruz M., García-Carrasco M. S., ánchez-Porras R., Mendo-za-Pinto C., Jiménez-Hernández M., Munguía-Realpozo P. Ruiz-Argūelles A., Autoimmun Rev., 2011, 10(12): 762.

[8]

Garcia-Molina M. M., Muñoz-Muñoz J. L., Garcia-Molina F., García-Ruiz P. A., Garcia-Canovas F. J. Agric. Food Chem., 2012, 60(25): 6447.

[9]

Ismaya W. T., Rozeboom H. J., Weijn A., Mes J. J., Fusetti F., Wichers H. J., Dijkstra B. W. Biochem., 2011, 50(24): 5477.

[10]

Wu C. Y., Sun Z. P., Ye Y. Y., Han X. H., Song X.Y., Liu S. Fitotera-pia, 2013, 91: 205.

[11]

Fitzpatrick T. B., Pathak M. A. J. Invest. Dermatol., 1959, 32(2): 229.

[12]

Yao L., Li Q., Shang J. J. Xinjiang Med. Univ., 2010, 33(10): 1191.

[13]

Zhou J., Shang J., Ping F. F., Zhao G. R. J. Ethnopharmacol., 2012, 143(2): 639.

[14]

Jois H. S., Manjunath B. L., Venkata R. S. J. Indian Chem. Soc., 1933, 10: 45.

[15]

Späth E. Ber. Deut. Chem. Ges., 1937, 70: 83.

[16]

El Mofty A. M. Vitiligo and Psoralens, 1968.

[17]

Fitzpatrick T. B., Parrish J. A., Pathak M. A. Phototherapy of Vitili-go(Idiopathic leukoderma) in Sunlight and Man, 1974.

[18]

Whitton M. E., Ashcroft D. M., González U. J. Am. Acad. Dermatol., 2008, 59(4): 713.

[19]

Felsten L. M., Alikhan A., Petronic-Rosic V. J. Am. Acad. Dermatol., 2011, 65(3): 493.

[20]

Tippisetty S., Goudi D., Mohammed A. W., Jahan P. Toxicol. In Vitro, 2013, 27(1): 38.

[21]

Kerns E. H., Di L. Drug Discov. Today, 2003, 8(7): 316.

[22]

Dreassi E., Zizzari A. T., Mori M., Filippi I., Belfiore A., Naldini A., Carraro F., Santucci A., Schenone S., Botta M. Eur. J. Med. Chem., 2010, 45(12): 5958.

[23]

Niu C., Pang G. X., Li G., Dou J., Nie L. F., Himit H., Kabas M., Aisa H. A. Bioorg. Med. Chem., 2016, 24(22): 5960.

[24]

Nakamura T., Wada H., Kurebayashi H., McInally T., Bonnert R., Isobe Y. Bioorg. Med. Chem. Lett., 2013, 23(3): 669.

[25]

Sensi M., Catani M., Castellano G., Nicolini G., Alciato F., Tragni G. De Santis G., Bersani I., Avanzi G., Tomassetti A., Canevari S., Ani-chini S., J. Invest. Dermatol., 2011, 131(12): 2448.

[26]

Roh E., Yun C. Y., Yun J. Y., Park D., Doo K. N., Yeon H. B., Jung S. H., Park S. K., Kim Y. B., Han S. B., Kim Y. J. Invest. Dermatol., 2013, 133(4): 1072.

[27]

Binda C., Wang J., Pisani L., Caccia C., Carotti A., Salvati P., Edmondson D. E., Mattevi A. J. Med. Chem., 2007, 50(23): 5848.

[28]

Chilin A., Manzini P., Caffieri S., Rodighiero P., Guiotto A. J. Heterocycl. Chem., 2001, 38(2): 431.

[29]

Patel J. M., Soman S. S. J. Heterocycl. Chem., 2010, 47(2): 379.

[30]

Chattopadhyay K., Fenster E., Grenning A. J. J., Tunge J. A. Beilstein J. Org. Chem., 2012, 8(133): 1200.

[31]

Kim H. J., Kim J. S., Woo J. T., Lee I. S., Cha B. Y. Acta Biochim. Biophys. Sin., 2015, 47(7): 548.

AI Summary AI Mindmap
PDF

93

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/